Protocol - Spirometry - Adult

Description

A spirometric test requires that the subject take a full, deep breath and then exhale as forcefully as possible into a handheld portable spirometer for several seconds. The subjects effort is called the forced expiratory maneuver and most commonly measures the amount and speed of air that is exhaled. The total amount (volume) of air exhaled is called the forced vital capacity (FVC). The amount of air exhaled in the first second is called the forced expiratory volume in 1 second (FEV1). Although handheld spirometers are commonly used in clinical research studies, the same results can be obtained from more-sophisticated floor-mounted devices, which are typically available in a respiratory function testing laboratory.

Specific Instructions

Numerous instructions are embedded in the protocol and in Table 1 of the protocol. This protocol is mainly for adults. The Spirometry - Preschool and Child protocol uses animated computer software and visual cues, which are necessary for young children.

The Sickle Cell Disease Curative Therapy Working Group recommends that this protocol be performed in transplant patients at one time point pre-transplant (baseline) and 100 days, six months, and annually post-hematopoietic cell transplant (HCT). The Working Group notes that a reduction in forced expiratory volume in 1 second (FEV1) can be caused by chronic graft versus host disease (GvHD) of the lungs.

Availability

This protocol is freely available; permission not required for use.

Download PDF

Protocol

The following description summarizes some of the key points. For the full protocol, see Miller et al., 2005.

Equipment

Spirometers usually come with computer software. The spirometer must be connected to a computer during the spirometry tests. Provide subjects with a mouthpiece and a noseclip. Use of a noseclip is highly recommended but not mandatory. Allow subjects to put the mouthpiece in their mouth and blow with the noseclip attached to their nose. Record whether the noseclip was used.

Quality control

To calibrate the spirometer, attach the device to a 3 liter syringe. Attach the spirometer to a computer and open the spirometry software to calibrate the spirometer. This calibration will measure the flow rate of the spirometer. Conduct three tests with the syringe and ensure that each result is ± 3% of the other tests. This is called a calibration check. Similarly, the syringe must also be calibrated; generally, the syringe flow rate results should be ± 0.5% of the other tests. Perform quality control tests on a weekly basis (see the manufacturer recommendations) and record the results in a log.

Demonstration

Provide a brief explanation of the spirometry test. Do multiple demonstrations of the spirometry test for each subject. Allow subjects to do practice attempts by putting their mouths on the spirometer, inhaling fully, and exhaling as forcefully as possible until no more air can be expelled. It may be useful to refer to the exhalation as a “blast” to ensure subjects exhale as forcefully as possible.

Setting

The subject should be sitting in a chair. Record the position (sitting or standing).

Successful maneuvers

After the subject blows into the spirometer, the technician determines whether the attempt was a successful “maneuver.” An adequate spirometry test requires a minimum of three acceptable maneuvers (see the full protocol for more details about successful maneuvers).

Recorded results

Record the following results.

Forced Vital Capacity (FVC)
Forced Expiratory Volume in 0.5 seconds (FEV_.5)
Forced Expiratory Volume in 0.75 seconds (FEV_.75)
Forced Expiratory Volume in 1 second (FEV₁)
Repeatability of parameters above (see repeatability maneuver criteria in full protocol)
Number of satisfactory attempts (maneuvers)
Posture (sitting/standing)

Nose clips (yes/no)

Personnel and Training Required

Technician trained in conducting Pulmonary Function Tests (PFTs) with a spirometer

Equipment Needs

The primary instrument used in pulmonary function testing is the spirometer.

Requirements

Requirement Category	Required
Major equipment	No
Specialized training	Yes
Specialized requirements for biospecimen collection	No
Average time of greater than 15 minutes in an unaffected individual	No

Mode of Administration

Physical Examination

Lifestage

Adolescent, Adult

Participants

Adults

Selection Rationale

Spirometry is invaluable as a screening test of general respiratory health. This protocol is the international standard supported by both the American Thoracic Society and the European Respiratory Society. The selected protocol is well-established over many years and serves as the unambiguous standard for lung function assessment in clinical research studies.

Language

Chinese, English

Standards

Standard	Name	ID	Source
Logical Observation Identifiers Names and Codes (LOINC)	Resp spirometry proto	62639-0	LOINC
caDSR Form	PhenX PX091601 - Spirometry	5970262	caDSR Form

Derived Variables

None

Process and Review

Expert Review Panel #6 (ERP 6) reviewed the measures in the Respiratory domain.

Guidance from the ERP 6 includes the following:

• No significant changes to measure

Back-compatible: no changes to the Data Dictionary

Previous version in Toolkit archive (link)

Protocol Name from Source

Miller, M. R., et al, Standardization of spirometry. Series “ATS/ERS task force: Standardization of lung function testing.”, EUR RESPIR J, 2005

Source

Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., . . . Wanger, J. (2005). Standardisation of spirometry. Series “ATS/ERS task force: Standardisation of lung function testing.” European Respiratory Journal, 26(2), 330-331.

General References

Andreeva, E., Pokhaznikova, M., Lebedev, A., Moiseeva, I., Kozlov, A., Kuznetsova, O., & Degryse, J. (2015). The RESPECT study: RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related etiology: a study protocol. BMC Public Health, 15(1), 831.

Berntsen, S., Stølevik, S. B., Mowinckel, P., Nystad, W., & Stensrud, T. (2016). Lung function monitoring; A randomized agreement study. Open Respiratory Medicine Journal, 10, 51-57.

Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey (NHANES) 2007-2008. Respiratory Health Spirometry Procedures Manual.

Protocol ID

91601

Variables

Export Variables

Variable Name	Variable ID	Variable Description	dbGaP Mapping
PX091601_Acceptable_Maneuver
	PX091601120000	Acceptable manoeuvre	Variable Mapping
PX091601_Age
	PX091601360000	Age	Variable Mapping
PX091601_Blank1_Or_FEF25
	PX091601640000	Blank 1 or FEF25%	Variable Mapping
PX091601_Blank3_Or_FEF75
	PX091601660000	Blank 3 or FEF75%	Variable Mapping
PX091601_Blank5
	PX091601680000	Blank 5	N/A
PX091601_Blank7
	PX091601700000	Blank 7	N/A
PX091601_Blank9
	PX091601720000	Blank 9	N/A
PX091601_BTPS_Calculation_Temperature
	PX091601050000	Temperature (ºC) used in BTPS calculation	N/A
PX091601_Calibration_Time
	PX091601300000	Calibration time	Variable Mapping
PX091601_Comments_Text
	PX091601620000	Comments text	Variable Mapping
PX091601_Computer_Quality
	PX091601140000	Computer quality code	Variable Mapping
PX091601_Country
	PX091601260000	Country	N/A
PX091601_Data_Type
	PX091601030000	Data type	N/A
PX091601_Date
	PX091601320000	Date	N/A
PX091601_Effort_Attribute
	PX091601090000	Effort attribute	N/A
PX091601_FEV1
	PX091601500000	FEV1	Variable Mapping
PX091601_FVC
	PX091601480000	FVC	Variable Mapping
PX091601_FVC_Quality
	PX091601070000	FVC quality attribute	Variable Mapping
PX091601_Methacholine_Concentration
	PX091601460000	Methacholine Concentration	N/A
PX091601_Number_Of_Data_Points
	PX091601740000	Number of data points	N/A
PX091601_PEF
	PX091601520000	PEF	Variable Mapping
PX091601_Phone_Number
	PX091601280000	Phone number	N/A
PX091601_Predicted_FEV1
	PX091601580000	Predicted FEV1	Variable Mapping
PX091601_Predicted_FEV1/FVC
	PX091601600000	Predicted FEV1/FVC%	Variable Mapping
PX091601_Race
	PX091601400000	Race (2-character race code)	Variable Mapping
PX091601_Reference_Value_Source
	PX091601420000	Reference values source (first author more surname and date of publication, e.g.''Knudson 1983'') show less	N/A
PX091601_Review
	PX091601160000	Review	N/A
PX091601_Reviewer_Initials
	PX091601180000	Reviewer initials	N/A
PX091601_Spirometer_Manufacturer
	PX091601200100	Spirometer manufacturer	N/A
PX091601_Spirometer_Serial_Number
	PX091601200300	Spirometer serial number	N/A
PX091601_State_Region
	PX091601240000	State/region	N/A
PX091601_Technician_ID
	PX091601340000	Technician ID	Variable Mapping
PX091601_Testing_Facility
	PX091601220000	Testing facility name	N/A
PX091601_Testing_Position
	PX091601440000	Testing position	Variable Mapping
PX091601_Time_To_PEF
	PX091601560000	Time to PEF	Variable Mapping
PX091601_VC
	PX091601540000	VC	Variable Mapping
PX091601_Weight
	PX091601380000	Weight	Variable Mapping

Respiratory

Measure Name

Spirometry

Release Date

January 29, 2010

Definition

Spirometry is a common pulmonary function test (PFT) measuring the amount (volume) and/or speed (flow) of air being inhaled and exhaled.

Purpose

Spirometry is a tool used to screen for the presence of obstructive and restrictive lung diseases.

Keywords

Respiratory, pulmonary function test, PFT, American Thoracic Society, ATS, European Respiratory Society, ERS, forced vital capacity, FVC, forced expiratory volume, FEV

Measure Protocols

Protocol ID	Protocol Name
91601	Spirometry - Adult
91602	Spirometry - Child

Mapping for PX091601_Acceptable_Maneuver

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083488	COMPLETED SPIROMETRY MANEUVER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083723	COMPLETED SPIROMETRY MANEUVER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087714	COMPLETED SPIROMETRY MANEUVER

Mapping for PX091601_Age

dbGAP Study	dbGAP Variable	dbGAP Variable Description
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173610	Age in days at time of testing
Autosomal recessive TPP2 mutations cause a new human immunodeficiency	phv00221155	Subject age
CARDIA Cohort	phv00116483	PATIENT DATA: DATE OF BIRTH
Characterization of Human Transcriptome by Computational and HTS Approaches	phv00224899	Subject age
Collaborative Study of Genes, Nutrients and Metabolites (CSGNM)	phv00252158	Age
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00032010	Date of birth
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090690	Date of birth
Discovery of Non-ETS Gene Fusions using RNA Sequencing	phv00142649	Age in years
DNA Methylation age and mortality in the Lothian Birth Cohorts	phv00219094	Age at baseline
Framingham Cohort	phv00164567	Age in years at baseline
Framingham Cohort	phv00056723	Age (age = formdate - DOB)
FusionSeq: Finding Fusions with Paired-End RNA-Seq	phv00156545	Age in years
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00081346	Age in Years
Genetic Discovery and Application in a Clinical Setting: Continuing a Partnership (eMERGE Phase II)	phv00252028	Age
Genetic Multiple Sclerosis Associations - GeneMSA	phv00073000	Birth date
Genetic Multiple Sclerosis Associations - GeneMSA	phv00072999	Age in years
GENEVA Diabetes Study (NHS/HPFS)	phv00022875	Age in years
Genotype-Tissue Expression (GTEx)	phv00169063	Age (Demography)
Jackson Heart Study (JHS) Cohort	phv00165330	Age in years at baseline
Jackson Heart Study (JHS) Cohort	phv00181208	Age in years at first participant visit
Melanoma Exome Sequencing	phv00226765	Subject age
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174654	Q3) HOW OLD ARE YOU? (PPT RESPONSE)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174655	Q3) HOW OLD ARE YOU?
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176077	Q3) HOW OLD ARE YOU? (PPT RESPONSE)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176078	Q3) HOW OLD ARE YOU?
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190304	Age in years at first participant visit
NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI)	phv00160321	Age in years at baseline LDL
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163946	Age in years at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190560	Age in years at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165163	Age in years at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178028	Age in years at baseline
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00024106	Subject's age at time of diagnosis in years, or the month and year the subject was born.
NINDS Repository Motor Neuron Disease/ALS Study	phv00000369	The age of the subject in years, or the month and year the subject was born.
Osteosarcoma Genomics	phv00220905	Age of patient at diagnosis
PD-1 Blockade in Non-Small Cell Lung Cancer	phv00253415	Patient's age
The Cardiopulmonary Effects of Particulate Exposure	phv00252410	Age of participant
The Genetic Landscape of Metastasis and Recurrence in HNSCC	phv00253504	Subject age
The Genomic Complexity of Primary Human Prostate Cancer	phv00154530	Age in years
The Human Virome and Febrile Illness in Children	phv00098404	Age in months when participant started study
The Human Virome and Febrile Illness in Children	phv00098403	Age in years when participant started study
Type 2 Diabetes Starr County GWAS and Exome Sequencing	phv00066506	Age in years
UIC ACE Exome Sequencing Analysis	phv00200228	Age Equivalent (AE) in months
Whole Genome Profiling to Detect Schizophrenia Methylation Markers	phv00191010	Age (in years)

Mapping for PX091601_Blank1_Or_FEF25

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095667	FEF(25) Q35
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095620	FEF(25)
CARDIA Cohort	phv00118965	FEF AT 25% FROM MAX CURVE (8 TRIALS)
CARDIA Cohort	phv00118936	FEF AT 25% FROM MAX CURVE (5 TRIALS)
CARDIA Cohort	phv00115682	FEF AT 25% FROM MAX CURVE
CARDIA Cohort	phv00114689	FEF AT 25% FROM MAX CURVE
Framingham Cohort	phv00073839	Forced expiratory flow at 25% of FVC - best effort
Framingham Cohort	phv00196593	Forced Expiratory Flow (FEF) at 25% of Forced Vital Capacity (FVC), (FEF25) - Best Effort, Albuterol
Framingham Cohort	phv00196576	Forced Expiratory Flow (FEF) at 25% of Forced Vital Capacity (FVC), (FEF25) - Best Effort, Albuterol
Framingham Cohort	phv00196559	Forced Expiratory Flow (FEF) at 25% of Forced Vital Capacity (FVC), (FEF25) - Best Effort
Framingham Cohort	phv00002688	LUNG FUNCTION: FEF (25)
Framingham Cohort	phv00022695	FORCED EXPIRATORY FLOW AT 25% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022684	FORCED EXPIRATORY FLOW AT 25% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022670	FORCED EXPIRATORY FLOW AT 25% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022659	FORCED EXPIRATORY FLOW AFTER 25% OF THE FVC HAS BEEN EXPIRED - SUMMARY
Framingham Cohort	phv00022644	FORCED EXPIRATORY FLOW AFTER 25% OF THE FVC HAS BEEN EXPIRED - TRIAL 5
Framingham Cohort	phv00022631	FORCED EXPIRATORY FLOW AFTER 25% OF THE FVC HAS BEEN EXPIRED - TRIAL 4
Framingham Cohort	phv00022618	FORCED EXPIRATORY FLOW AFTER 25% OF THE FVC HAS BEEN EXPIRED - TRIAL 3
Framingham Cohort	phv00022605	FORCED EXPIRATORY FLOW AFTER 25% OF THE FVC HAS BEEN EXPIRED - TRIAL 1
Framingham Cohort	phv00022592	FORCED EXPIRATORY FLOW AFTER 25% OF THE FVC HAS BEEN EXPIRED - TRIAL 1
Framingham Cohort	phv00022576	FORCED EXPIRATORY FLOW AT 25% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022561	FORCED EXPIRATORY FLOW AT 25% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00003255	LUNG FUNCTION: FEF (25)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083455	FORCED EXPIRATORY FLOW 25% (ml/sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083690	FORCED EXPIRATORY FLOW 25% (ml/sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087681	FORCED EXPIRATORY FLOW 25% (ml/sec)
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122581	Spirometry: forced expiratory flow at 25

Mapping for PX091601_Blank3_Or_FEF75

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095964	FEF(75) Predicted
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095955	FEF(75) Predicted
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095669	FEF(75) Q37
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095622	FEF(75)
CARDIA Cohort	phv00118967	FEF AT 75% FROM MAX CURVE (8 TRIALS)
CARDIA Cohort	phv00118938	FEF AT 75% FROM MAX CURVE (5 TRIALS)
CARDIA Cohort	phv00115684	FEF AT 75% FROM MAX CURVE
CARDIA Cohort	phv00114691	FEF AT 75% FROM MAX CURVE
Framingham Cohort	phv00003257	LUNG FUNCTION: FEF (75)
Framingham Cohort	phv00196595	Forced Expiratory Flow (FEF) at 75% of Forced Vital Capacity (FVC), (FEF75) - Best Effort, Albuterol
Framingham Cohort	phv00196578	Forced Expiratory Flow (FEF) at 75% of Forced Vital Capacity (FVC), (FEF75) - Best Effort, Albuterol
Framingham Cohort	phv00196561	Forced Expiratory Flow (FEF) at 75% of Forced Vital Capacity (FVC), (FEF75) - Best Effort
Framingham Cohort	phv00073841	Forced expiratory flow at 75% of FVC - best effort
Framingham Cohort	phv00022697	FORCED EXPIRATORY FLOW AT 75% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022686	FORCED EXPIRATORY FLOW AT 75% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022672	FORCED EXPIRATORY FLOW AT 75% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022661	FORCED EXPIRATORY FLOW AFTER 75% OF THE FEV HAS BEEN EXPIRED - SUMMARY
Framingham Cohort	phv00022646	FORCED EXPIRATORY FLOW AFTER 75% OF THE FEV HAS BEEN EXPIRED - TRIAL 5
Framingham Cohort	phv00022633	FORCED EXPIRATORY FLOW AFTER 75% OF THE FEV HAS BEEN EXPIRED - TRIAL 4
Framingham Cohort	phv00022620	FORCED EXPIRATORY FLOW AFTER 75% OF THE FEV HAS BEEN EXPIRED - TRIAL 3
Framingham Cohort	phv00022607	FORCED EXPIRATORY FLOW AFTER 75% OF THE FEV HAS BEEN EXPIRED - TRIAL 2
Framingham Cohort	phv00022594	FORCED EXPIRATORY FLOW AFTER 75% OF THE FEV HAS BEEN EXPIRED - TRIAL 1
Framingham Cohort	phv00022578	FORCED EXPIRATORY FLOW AT 75% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022563	FORCED EXPIRATORY FLOW AT 75% OF FVC (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00002690	LUNG FUNCTION: FEF (75)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083457	FORCED EXPIRATORY FLOW 75% (ml/sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083692	FORCED EXPIRATORY FLOW 75% (ml/sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087683	FORCED EXPIRATORY FLOW 75% (ml/sec)
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122583	Spirometry: forced expiratory flow at 75

Mapping for PX091601_Calibration_Time

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083450	CALIBRATION TIME
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083685	CALIBRATION TIME
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087676	CALIBRATION TIME

Mapping for PX091601_Comments_Text

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175852	LAA COMMENT
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175853	EXTRA COMMENT
NHGRI Tumor Sequencing Project (Lung Adenocarcinoma)	phv00071776	Comment on WGA QA failure

Mapping for PX091601_Computer_Quality

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Jackson Heart Study (JHS) Cohort	phv00128203	Computer QC (Flow) - Quality Control Score assigned by computer for flow aspects of curve
Jackson Heart Study (JHS) Cohort	phv00128204	Computer QC (Volume) - Quality Control Score assigned by computer for volume aspects

Mapping for PX091601_FEV1

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095612	FEV(1) (liters)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095659	FEV(1) (liters) Q26
CARDIA Cohort	phv00113318	FEV1, TRIAL 6
CARDIA Cohort	phv00113263	FEV1, TRIAL 1
CARDIA Cohort	phv00113274	FEV1, TRIAL 2
CARDIA Cohort	phv00113285	FEV1, TRIAL 3
CARDIA Cohort	phv00113296	FEV1, TRIAL 4
CARDIA Cohort	phv00113307	FEV1, TRIAL 5
CARDIA Cohort	phv00113403	MAXIMUM FEV1
CARDIA Cohort	phv00114695	MAXIMUM FEV1
CARDIA Cohort	phv00115688	MAXIMUM FEV1
CARDIA Cohort	phv00118942	MAXIMUM FEV1 (5 TRIALS)
CARDIA Cohort	phv00118971	MAXIMUM FEV1 (8 TRIALS)
Cardiovascular Health Study (CHS) Cohort	phv00110365	FEV1 (L)
Cardiovascular Health Study (CHS) Cohort	phv00107763	FEV1 (L)
Cardiovascular Health Study (CHS) Cohort	phv00099665	FEV1 (L)
Framingham Cohort	phv00196583	Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers, Albuterol
Framingham Cohort	phv00182413	FEV1 measurement at the first available visit (only for HeartGO)
Framingham Cohort	phv00196549	Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers
Framingham Cohort	phv00196566	Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers, Albuterol
Framingham Cohort	phv00002684	LUNG FUNCTION: FEV1
Framingham Cohort	phv00003251	LUNG FUNCTION: FEV1
Framingham Cohort	phv00022586	FORCED EXPIRATORY VOLUME - TRIAL 1 IN 1.0 SECONDS
Framingham Cohort	phv00022598	FORCED EXPIRATORY VOLUME - TRIAL 1 IN 1.0 SECONDS
Framingham Cohort	phv00022611	FORCED EXPIRATORY VOLUME - TRIAL 3 IN 1.0 SECONDS
Framingham Cohort	phv00022637	FORCED EXPIRATORY VOLUME - TRIAL 5 IN 1.0 SECONDS
Framingham Cohort	phv00022652	FORCED EXPIRATORY VOLUME - SUMMARY IN 1.0 SECONDS
Framingham Cohort	phv00055265	Forced Expiratory Volume in One Second (Litres)
Genetic Epidemiology of COPD (COPDGene)	phv00159853	FEV1 pre-bronch
Genome-Wide Association Study of Serum YKL-40 Levels	phv00066568	Forced expiratory volume in 1 second
Jackson Heart Study (JHS) Cohort	phv00181269	Forced expiratory volume (FEV1) measurement at the first available visit
Jackson Heart Study (JHS) Cohort	phv00128230	THRD_FEV1 - Forced expiratory volume in 1 second, FEV1.0 from the 3rd best curve: measured in liters
Jackson Heart Study (JHS) Cohort	phv00128220	SCND_FEV1 - Forced expiratory volume in 1 second, FEV1.0 from the 2nd best curve: measured in liters
Jackson Heart Study (JHS) Cohort	phv00128210	BEST_FEV1 - Forced expiratory volume in 1 second, FEV1.0 from the best curve: measured in liters
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083694	LOWER LIMIT OF NORMAL: FEV1 (ml/sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087685	LOWER LIMIT OF NORMAL: FEV1 (ml/sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083459	LOWER LIMIT OF NORMAL: FEV1 (ml/sec)
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190390	Forced expiratory volume (FEV1) measurement at the first available visit
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122577	Spirometry: forced exp vol, 1st sec
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00123041	Standardized Knudson predictor: FEV1
NHLBI GO-ESP: Family Studies (Atypical Cystic Fibrosis)	phv00179563	Forced expiratory volume
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00190437	FEV1 measurement at the first available visit (only for HeartGO)
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190629	FEV1 measurement at the first available visit (only for HeartGO)
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178108	FEV1 measurement at the first available visit (only for HeartGO)
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis)	phv00159435	Forced Expiratory Volume (liters) in 1 sec (max of 3 trials)
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071189	Baseline FEV1
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070972	Baseline FEV1
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071235	FEV1 at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00076230	Maximum FEV1 (following 4, 6, or 8 puffs of albuterol) at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071132	Post-FEV1 at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071127	FEV1 at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071081	Baseline FEV1
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00076237	Maximum FEV1 (following 4, 6, or 8 puffs of albuterol) at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071024	Post-FEV1 at follow-up visit
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071019	FEV1 at follow-up visit

Mapping for PX091601_FVC

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095657	FVC (liters) Q24
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095610	FVC (liters)
CARDIA Cohort	phv00113317	FVC, TRIAL 6
CARDIA Cohort	phv00115632	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00114675	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00114663	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00114651	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00114639	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00114627	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00114615	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00113402	MAXIMUM FVC
CARDIA Cohort	phv00115620	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00113306	FVC, TRIAL 5
CARDIA Cohort	phv00113262	FVC, TRIAL 1
CARDIA Cohort	phv00113273	FVC, TRIAL 2
CARDIA Cohort	phv00113284	FVC, TRIAL 3
CARDIA Cohort	phv00113295	FVC, TRIAL 4
CARDIA Cohort	phv00115656	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00118970	MAXIMUM FVC (8 TRIALS)
CARDIA Cohort	phv00118941	MAXIMUM FVC (5 TRIALS)
CARDIA Cohort	phv00118923	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00118911	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00118899	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00118887	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00118875	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00118863	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00118851	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00118839	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00115668	FORCED VITAL CAPACITY, TRIAL
CARDIA Cohort	phv00115644	FORCED VITAL CAPACITY, TRIAL
Cardiovascular Health Study (CHS) Cohort	phv00099664	FVC (L)
Cardiovascular Health Study (CHS) Cohort	phv00107762	FVC (L)
Cardiovascular Health Study (CHS) Cohort	phv00110364	FVC
Framingham Cohort	phv00196586	Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers, Albuterol
Framingham Cohort	phv00182414	FVC measurement at the first available visit (only for HeartGO)
Framingham Cohort	phv00196552	Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers
Framingham Cohort	phv00196569	Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers, Albuterol
Framingham Cohort	phv00002682	LUNG-FUNCTION: FORCED VITAL CAPACITY
Framingham Cohort	phv00003249	LUNG-FUNCTION: FORCED VITAL CAPACITY
Framingham Cohort	phv00022597	FORCED VITAL CAPACITY - TRIAL 1
Framingham Cohort	phv00022610	FORCED VITAL CAPACITY - TRIAL 3
Framingham Cohort	phv00022623	FORCED VITAL CAPACITY - TRIAL 4
Framingham Cohort	phv00022636	FORCED VITAL CAPACITY - TRIAL 5
Framingham Cohort	phv00022651	FORCED VITAL CAPACITY - SUMMARY
Framingham Cohort	phv00022664	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
Framingham Cohort	phv00022678	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
Framingham Cohort	phv00022689	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
Framingham Cohort	phv00055266	Forced Vital Capacity (Litres)
Framingham Cohort	phv00073832	Forced vital capacity - highest value among acceptable maneuvers
Framingham Cohort	phv00022584	FORCED VITAL CAPACITY - TRIAL 1
Framingham Cohort	phv00022571	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
Framingham Cohort	phv00022555	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
Genetic Epidemiology of COPD (COPDGene)	phv00159852	FVC post-bronch
Genetic Epidemiology of COPD (COPDGene)	phv00159854	FVC pre-bronch
Genome-Wide Association Study of Serum YKL-40 Levels	phv00066569	Forced vital capacity
Genome-Wide associations of Lung Health Study (LHS)	phv00154603	Accept Annual Visit2 Pre Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154624	Accept Annual Visit5 Post Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154600	Accept Annual Visit1 Post Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154597	Accept Annual Visit1 Pre Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154572	Accept s3 Pre Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154569	Accept s2 Post Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154606	Accept Annual Visit2 Post Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154609	Accept Annual Visit3 Pre Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154612	Accept Annual Visit3 Post Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154615	Accept Annual Visit4 Pre Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154618	Accept Annual Visit4 Post Max FVC
Genome-Wide associations of Lung Health Study (LHS)	phv00154621	Accept Annual Visit5 Pre Max FVC
Jackson Heart Study (JHS) Cohort	phv00128209	BEST_FVC - Best forced vital capacity from best curve (best curve is an acceptable curve that has Max [FVC + FEV1 ] ): measured in liters
Jackson Heart Study (JHS) Cohort	phv00181300	FVC measurement at the first available visit (only for HeartGO)
Jackson Heart Study (JHS) Cohort	phv00181270	Forced vital capacity (FVC) measurement at the first available visit
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087700	FORCED VITAL CAPACITY (ml)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087684	LOWER LIMIT OF NORMAL: FVC (ml)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083709	FORCED VITAL CAPACITY (ml)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083693	LOWER LIMIT OF NORMAL: FVC (ml)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083474	FORCED VITAL CAPACITY (ml)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083458	LOWER LIMIT OF NORMAL: FVC (ml)
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190391	Forced vital capacity (FVC) measurement at the first available visit
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00123040	Standardized Knudson predictor: FVC
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122575	Spirometry: forced vital capacity (FVC)
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00190438	FVC measurement at the first available visit (only for HeartGO)
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190630	FVC measurement at the first available visit (only for HeartGO)
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00181195	FVC measurement at the first available visit (only for HeartGO)
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178109	FVC measurement at the first available visit (only for HeartGO)
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071190	Baseline FVC
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071236	FVC at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071128	FVC at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071082	Baseline FVC
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071025	Post-FVC at follow-up visit
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071020	FVC at follow-up visit
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070973	Baseline FVC

Mapping for PX091601_FVC_Quality

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Jackson Heart Study (JHS) Cohort	phv00128206	Reader QC (FVC) - Pulmonary reading center reader quality score for forced vital capacity
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083442	FVC QUALITY ASSURANCE GRADE
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083470	FVC QUALITY ASSURANCE GRADE: NUMERIC
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083677	FVC QUALITY ASSURANCE GRADE
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083705	FVC QUALITY ASSURANCE GRADE: NUMERIC
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087668	FVC QUALITY ASSURANCE GRADE
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087696	FVC QUALITY ASSURANCE GRADE: NUMERIC

Mapping for PX091601_PEF

dbGAP Study	dbGAP Variable	dbGAP Variable Description
CARDIA Cohort	phv00115680	PEAK EXPIRATORY FLOW RATE FR MAX CURVE
CARDIA Cohort	phv00114687	PEAK EXPIRATORY FLOW RATE FR MAX CURVE
Cardiovascular Health Study (CHS) Cohort	phv00110372	Best PEF
Cardiovascular Health Study (CHS) Cohort	phv00110368	Predicted PEF
Framingham Cohort	phv00022572	PEAK EXPIRATORY FLOW (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00196587	Peak Expiratory Flow (FEFMAX) - Highest value among acceptable maneuvers, Albuterol
Framingham Cohort	phv00196570	Peak Expiratory Flow (FEFMAX) - Highest value among acceptable maneuvers, Albuterol
Framingham Cohort	phv00196553	Peak Expiratory Flow (FEFMAX) - Highest value among acceptable maneuvers
Framingham Cohort	phv00073833	Peak expiratory flow - best effort
Framingham Cohort	phv00022691	PEAK EXPIRATORY FLOW (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022666	PEAK EXPIRATORY FLOW (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022557	PEAK EXPIRATORY FLOW (LIT./SEC.) - BEST EFFORT
Framingham Cohort	phv00022590	PEAK EXPIRATORY FLOW RATE - TRIAL 1 (MAXIMUM RATE OF FLOW ATTAINABLE AT ANY TIME DURING AN FEV)
Framingham Cohort	phv00022603	PEAK EXPIRATORY FLOW RATE - TRIAL 1 (MAXIMUM RATE OF FLOW ATTAINABLE AT ANY TIME DURING AN FEV)
Framingham Cohort	phv00022616	PEAK EXPIRATORY FLOW RATE - TRIAL 3 (MAXIMUM RATE OF FLOW ATTAINABLE AT ANY TIME DURING AN FEV)
Framingham Cohort	phv00022629	PEAK EXPIRATORY FLOW RATE - TRIAL 4 (MAXIMUM RATE OF FLOW ATTAINABLE AT ANY TIME DURING AN FEV)
Framingham Cohort	phv00022642	PEAK EXPIRATORY FLOW RATE - TRIAL 5 (MAXIMUM RATE OF FLOW ATTAINABLE AT ANY TIME DURING AN FEV)
Framingham Cohort	phv00022657	PEAK EXPIRATORY FLOW RATE - SUMMARY (MAXIMUM RATE OF FLOW ATTAINABLE AT ANY TIME DURING AN FEV)
Framingham Cohort	phv00022682	PEAK EXPIRATORY FLOW (LIT./SEC.) - BEST EFFORT
Genetic Epidemiology of COPD (COPDGene)	phv00169393	PEF post-bronch
Genetic Epidemiology of COPD (COPDGene)	phv00169396	PEF pre-bronch
Jackson Heart Study (JHS) Cohort	phv00128211	BEST_PEF - Peak expiratory flow from the best curve: measured in liters
Jackson Heart Study (JHS) Cohort	phv00128221	SCND_PEF - Peak expiratory flow from the 2nd best curve: measured in liters per second
Jackson Heart Study (JHS) Cohort	phv00128231	THRD_PEF - Peak expiratory flow from the 3rd best curve: measured in liters per second
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087703	PEAK EXPIRATORY FLOW (ml/sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083712	PEAK EXPIRATORY FLOW (ml/sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083477	PEAK EXPIRATORY FLOW (ml/sec)
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122580	Spirometry: peak expiratory flow
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00123042	Standardized Knudson predictor: PEF

Mapping for PX091601_Predicted_FEV1

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095950	FEV(1) Predicted (liters)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095967	FEV(1) Predicted (Liters)
Cardiovascular Health Study (CHS) Cohort	phv00099671	FEV PREDICTED VALUE
Genome-Wide associations of Lung Health Study (LHS)	phv00154570	Accept s2 Post % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154573	Accept s3 Pre % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154598	Accept Annual Visit1 Pre % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154601	Accept Annual Visit1 Post % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154604	Accept Annual Visit2 Pre % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154607	Accept Annual Visit2 Post % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154610	Accept Annual Visit3 Pre % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154613	Accept Annual Visit3 Post % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154616	Accept Annual Visit4 Pre % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154619	Accept Annual Visit4 Post % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154622	Accept Annual Visit5 Pre % Pred FEV1
Genome-Wide associations of Lung Health Study (LHS)	phv00154625	Accept Annual Visit5 Post % Pred FEV1

Mapping for PX091601_Predicted_FEV1/FVC

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095965	FEF(1)/FVC Predicted(%)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095957	FEV(1)/FVC Predicted (%)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095664	FEV(1) over FVC Q31
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095617	FEV(1) over FVC
CARDIA Cohort	phv00113308	FEV1/FVC, TRIAL 5
CARDIA Cohort	phv00115622	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00114677	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00114665	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00114653	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00114641	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00114629	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00114617	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00113414	RATIO OF MAXIMUM FEV1 TO FVC
CARDIA Cohort	phv00113319	FEV1/FVC, TRIAL 6
CARDIA Cohort	phv00114706	RATIO OF MAXIMUM FEV1 TO FVC
CARDIA Cohort	phv00113297	FEV1/FVC, TRIAL 4
CARDIA Cohort	phv00113264	FEV1/FVC, TRIAL 1
CARDIA Cohort	phv00113275	FEV1/FVC, TRIAL 2
CARDIA Cohort	phv00113286	FEV1/FVC, TRIAL 3
CARDIA Cohort	phv00115634	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00118982	RATIO OF MAXIMUM FEV1 TO FVC (8 TRIALS)
CARDIA Cohort	phv00118953	RATIO OF MAXIMUM FEV1 TO FVC (5 TRIALS)
CARDIA Cohort	phv00118925	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00118913	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00118901	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00118889	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00118877	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00118865	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00118853	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00118841	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00115699	RATIO OF MAXIMUM FEV1 TO FVC
CARDIA Cohort	phv00115670	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00115658	RATIO FEV1/FVC, TRIAL
CARDIA Cohort	phv00115646	RATIO FEV1/FVC, TRIAL
Cardiovascular Health Study (CHS) Cohort	phv00099666	FEV1/FVC (%)
Cardiovascular Health Study (CHS) Cohort	phv00099672	(FEV1/FVC) PREDICTED VALUE
Framingham Cohort	phv00022565	RATIO FEV1/FVC (CALCULATED VARIABLE) - BEST EFFORT
Framingham Cohort	phv00196574	Ratio best FEV1 / best FVC (calculated variable), Albuterol
Framingham Cohort	phv00196557	Ratio Best FEV1 / Best FVC (calculated variable)
Framingham Cohort	phv00196591	Ratio Best FEV1 / Best FVC (calculated variable), Albuterol
Framingham Cohort	phv00022699	RATIO FEV1/FVC (CALCULATED VARIABLE) - BEST EFFORT
Framingham Cohort	phv00022574	RATIO FEV1/FVC (CALCULATED VARIABLE) - BEST EFFORT
Framingham Cohort	phv00022585	RATIO: FEV1 TO FVC - TRIAL 1
Framingham Cohort	phv00022600	RATIO: FEV1 TO FVC - TRIAL 2
Framingham Cohort	phv00022613	RATIO: FEV1 TO FVC - TRIAL 3
Framingham Cohort	phv00022626	RATIO: FEV1 TO FVC - TRIAL 4
Framingham Cohort	phv00022639	RATIO: FEV1 TO FVC - TRIAL 5
Framingham Cohort	phv00022654	RATIO: FEV1 TO FVC - SUMMARY
Framingham Cohort	phv00022674	RATIO FEV1/FVC (CALCULATED VARIABLE) - BEST EFFORT
Framingham Cohort	phv00022681	RATIO FEV1/FVC (CALCULATED VARIABLE) - BEST EFFORT
Framingham Cohort	phv00073837	Ratio best FEV1/best FVC (calculated variable)
Genetic Epidemiology of COPD (COPDGene)	phv00159855	FEV1/FVC pre-bronch
Genome-Wide Association Study in Systemic Sclerosis	phv00161651	PFT4 FEV1/FVC % predicted.
Genome-Wide Association Study in Systemic Sclerosis	phv00161646	PFT3 FEV1/FVC % predicted.
Genome-Wide Association Study in Systemic Sclerosis	phv00161641	PFT2 FEV1/FVC % predicted.
Genome-Wide Association Study in Systemic Sclerosis	phv00161636	PFT1 FEV1/FVC % predicted.
Genome-Wide Association Study of Serum YKL-40 Levels	phv00066570	Forced expiratory volume in 1 second to forced vital capacity ratio
Jackson Heart Study (JHS) Cohort	phv00128234	THRD_FEV1_FVC - FEV1/FVC % from 3rd best curve
Jackson Heart Study (JHS) Cohort	phv00128224	SCND_FEV1_FVC - FEV1/FVC % from second best curve
Jackson Heart Study (JHS) Cohort	phv00128214	BEST_FEV1_FVC - FEV1/FVC % from best curve
Jackson Heart Study (JHS) Cohort	phv00128207	Reader QC (FEV1) - Pulmonary reading center reader quality score for FEV 1.0
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083697	LOWER LIMIT OF NORMAL: FEV1/FEV6 RATIO
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087708	FEV1/FVC RATIO
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087687	LOWER LIMIT OF NORMAL: FEV1/FVC RATIO
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083837	FEV1/FVC PREDICTED
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083717	FEV1/FVC RATIO
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083696	LOWER LIMIT OF NORMAL: FEV1/FVC RATIO
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083607	FEV1/FVC PREDICTED
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083482	FEV1/FVC RATIO
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083461	LOWER LIMIT OF NORMAL: FEV1/FVC RATIO
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087833	FEV1/FVC PREDICTED
NIA Long Life Family Study (LLFS)	phv00163267	FEV1/FVC ratio (%), i.e. Forced Expiratory Volume in one Second (FEV1) / Forced Vital Capacity (FVC)
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070974	Baseline FEV1/FVC ratio
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071021	FEV1/FVC ratio at follow-up visit
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071026	Post-FEV1/FVC ratio at follow-up visit
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071083	Baseline FEV1/FVC ratio
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071129	FEV1/FVC ratio at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071134	Post-FEV1/FVC ratio at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071191	Baseline FEV1/FVC ratio
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071237	FEV1/FVC ratio at Follow-up

Mapping for PX091601_Race

dbGAP Study	dbGAP Variable	dbGAP Variable Description
A Genome-Wide Association Study of Fuchs' Endothelial Corneal Dystrophy (FECD)	phv00181940	Racial Category
A Genome-Wide Association Study of Peripheral Arterial Disease	phv00076112	Race of participant
A Multiethnic GWAS of Prostate Cancer	phv00124440	Self reported race/ethnicity
A Multiethnic GWAS of Prostate Cancer	phv00142465	Self reported race/ethnicity
A Multiethnic GWAS of Prostate Cancer	phv00142486	Self reported race/ethnicity
Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes	phv00076150	Subject's Race
ADGC Genome Wide Association Study	phv00171928	Self-reported race of participant
Alcohol Dependence GWAS in European- and African Americans	phv00164979	Race of participant
Alzheimer's Disease Sequencing Project (ADSP)	phv00192289	NIH Racial Categories
Alzheimer's Disease Sequencing Project (ADSP)	phv00195364	NIH Racial Categories
Alzheimer's Disease Sequencing Project (ADSP)	phv00218095	NIH Racial Categories
ARDSnet and the iSPAAR Consortium: Genetic Studies	phv00196259	Race
ARRA Autism Sequencing Collaboration	phv00167342	Race of participant
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091485	RACE (from FTRA23)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092764	RACE (from FTRA23)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092847	RACE (from FTRA23)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092940	RACE (from FTRA23)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00093021	RACE (from FTRA23)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00097871	RACE (from FTRA23)
Autopsy-Confirmed Parkinson Disease GWAS Consortium (APDGC)	phv00167766	Race of participant [African American, Asian, Asian-American, Hispanic, Hispanic- Cauc, Non-White, White, Unknown]
BrainCloud: Data from Human Postmortem Brain Across the Lifespan	phv00163197	Race of subject
CALGB 80303: Genome-Wide Association Study of Advanced Pancreatic Cancer Patients	phv00159014	Race. This variable is the self reported race of the patient at the time of registration. Patients who report more than one race are categorized as having multiple races.
CARDIA Cohort	phv00112422	EXAM 1 RACE, TELEPHONE INTERVIEW
CARDIA Cohort	phv00113715	RACE (VERIFIED AY EXAM 2)
CARDIA Cohort	phv00114607	RACE CODE
CARDIA Cohort	phv00115113	RACE (VERIFIED AT EXAM 2)
CARDIA Cohort	phv00116379	RACE (VERIFIED AY EXAM 2)
CARDIA Cohort	phv00117580	RACE (VERIFIED AY EXAM 2)
CARDIA Cohort	phv00119632	RACE (VERIFIED AT PPTS LAST EXAM)
CARDIA Cohort	phv00120740	RACE (VERIFIED AT PPTS LAST EXAM)
Cardiovascular Health Study (CHS) Cohort	phv00099569	RACE
Cardiovascular Health Study (CHS) Cohort	phv00100488	RACE
Cardiovascular Health Study (CHS) Cohort	phv00100837	RACE
Cardiovascular Health Study (CHS) Cohort	phv00105645	RACE
Cardiovascular Health Study (CHS) Cohort	phv00197397	Race from a-variables table
Cardiovascular Health Study (CHS) Cohort	phv00197401	Race
CATHGEN: Genetic Mediators of Metabolic Cardiovascular Disease Risk	phv00197206	Race of participant defined by population stratification
CATHGEN: Identification of Novel Genetic and Metabolomic CV Phenotypes	phv00197186	Race of participant defined by population stratification
CCDG: Dental Caries and CL/P in Guatemala	phv00164772	Race of Individual.
CCDG: Dental Caries and CL/P in Guatemala	phv00164849	Race of participant.
CCHMC - eMERGE Data	phv00171347	Race of participant
Characterization of a Metastatic Cervical Cancer Using NGS	phv00195733	Race of participant
Characterization of Pancreatic Adenocarcinoma Patients Using NGS	phv00179510	Race of participant
Chinese Alternating Hemiplegia of Childhood (AHC) Disease Study	phv00195756	Race of participant
Cholesterol and Pharmacogenetics (CAP) Study	phv00167791	Self-reported ethnicity (>=3 of 4 grandparents)
CHOP Control CNV Study	phv00076213	Race of participant
Chronic Renal Insufficiency Cohort Study (CRIC)	phv00173282	Race-Ethnicity Category (4-level)
CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)	phv00045172	Race: 1 = White; 2 = Black; 3 = Hispanic; 4 = Asian or Pacific Islander; 5 = American Indian or Alaskan Native; 6 = Other; 7 = Unknown; U = Unavailable
CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)	phv00045240	Race (see phs000004: NINDS Repository Neurologically Normal Control Collection).
CIDR: NGRC Parkinson's Disease Study	phv00075999	Self report of race, per NIH classification.
CPMCRI Breast Health Cohort	phv00162747	Participant's race
CTLA4 haploinsufficiency and immune dysregulation	phv00217702	Subject's race
Cutaneous Microbiome in Psoriasis (HMP Demonstration Study)	phv00090656	Race of participant
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027636	Patient's race
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030308	Patient's race
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030700	Patient's race
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030768	Patient's race
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034145	Patient's race
Dental Caries GWAS	phv00090197	Race of Individual
Dental Caries GWAS	phv00165470	Race of Individual
Diabetes Prevention Program Genetics (DPPG)	phv00201855	Race of participant
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090693	Race
DNA Methylation Analysis of Prostate Cancer	phv00181137	Race of subject
Drug Resistant Hypertension in African Americans' Exome	phv00164735	Race of participant
Effect of Crohn's Disease Risk Alleles on Enteric Microbiota	phv00090596	Race of participant
eMERGE Network Combined Dataset	phv00182448	Race of participant
eMERGE Network Study of Resistant Hypertension	phv00163161	Race of participant.
Epigenetic Marks as Peripheral Biomarkers of Autism	phv00191074	Race of participant
Exome Chip Study of NIMH Controls	phv00192232	Race of participant
Exome Sequencing in Schizophrenia Families	phv00201669	Race of participant
Familial Exome Sequencing in Rare Pediatric Phenotypes	phv00179540	Race of participant
Family Investigation of Nephropathy and Diabetes (FIND) Study	phv00161413	Race
Framingham Cohort	phv00055250	Race
Framingham Cohort	phv00182405	Self report race
Gene expression in CAD	phv00174370	Race
Genentech Lung Cancer Sequencing	phv00112392	Race
Genetic Associations in Idiopathic Talipes Equinovarus (GAIT)	phv00141839	Race/Ethnicity of participant
Genetic Basis of XMEN Disease	phv00160300	Race of participant
Genetic Epidemiology Network of Salt Sensitivity (GenSalt)	phv00217809	Race - All are Han Chinese
Genetic Epidemiology of COPD (COPDGene)	phv00159572	Race
Genetic Measurement of Memory B-cell Recall Using Antibody Repertoire Sequencing	phv00195587	Race of participant
Genetic Predictors of Adverse Radiotherapy Effects (Gene-PARE)	phv00202678	Self-reported race/ethnicity of participant [Black, Asian, Caucasian, Hispanic]
Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR Project)	phv00071846	Subject's race
Genetics of Cerebral Hemorrhage with Anticoagulation (GOCHA)	phv00169276	Subject's race
Genetics of Neuropsychiatric and Neurodevelopmental Disorders	phv00196237	Race of participant
Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort	phv00165040	Race of participant
GENEVA Genetics of Early Onset Stroke (GEOS) Study	phv00111928	Self-reported race
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00022833	Race
Genome Variations Among the Aboriginals in Malaysia	phv00195916	Race of participant
Genome Wide Association Studies in ECOG 2997 Trial	phv00190917	NCI Race
Genome, Epigenome and RNA Sequences of MZ Twins Discordant for MS	phv00090330	Race of participant
Genome-Wide Association Study of Amyotrophic Lateral Sclerosis in Finland	phv00158890	Race of participant
Genome-Wide Association Study of Neuroblastoma	phv00158910	Race of subject
Genome-Wide Association Study of Relapse of Childhood Acute Lymphoblastic Leukemia	phv00196102	Race genetcially determined using STRUCTURE with genome-wide mapping array
Genome-Wide Association Study of Schizophrenia	phv00020243	Race/ethnicity
Genome-Wide Association Study of Schizophrenia	phv00034900	Race/ethnicity
Genome-Wide associations of Lung Health Study (LHS)	phv00154567	Race
Genomic Origins and Admixture in Latinos (GOAL)	phv00202273	Race of participant
Genomic Sequencing of Colorectal Adenocarcinomas	phv00162709	Race using US census definitions
Genomic Sequencing of Solitary Fibrous Tumors	phv00179055	Race of participant
Genotype-Tissue Expression (GTEx)	phv00169064	Race
Germline Sequencing for Aggressive Prostate Carcinoma	phv00195900	Subject's race
Group Health/UW Aging and Dementia eMERGE Study	phv00088202	Race of Participant
GWAS for Genetic Determinants of Bone Fragility	phv00065503	Race of participant
GWAS of Breast Cancer in the African Diaspora	phv00172014	Race of participant [African American, African, African Barbadian]
GWAS of Familial Lung Cancer	phv00192255	Race of participant
GWAS on Cataract and HDL in the PMRP	phv00076431	Race of partipant
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)	phv00174313	Race/ethnicity
HIV-1 Host Genetics Among Injection Drug Users	phv00167741	Self-reported ancestry of participant
HIV-Resistant People with Hemophilia	phv00165019	Race of participant [African American, European, Hispanic American]
Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas	phv00201614	Race of participant
IMSGC Genome Wide Association Study of Multiple Sclerosis	phv00065551	NIH racial background
International Consortium to Identify Genes and Interactions Controlling Oral Clefts	phv00088045	Individual's Race
Ischemic Stroke Genetics Study (ISGS)	phv00024266	Race of the subject
Jackson Heart Study (JHS) Cohort	phv00181206	Self report race
Jackson Heart Study (JHS) Cohort	phv00181284	Self report race [African American]
Joint Genome-Wide Gene Expression and GWAS Mapping in the MGS Dataset	phv00202326	Race of participant
L1-seq and genome-wide SNP genotyping in a multiethnic Asian population	phv00201447	Race of participant
Medulloblastoma exome sequence analysis	phv00171449	Participant's race using US census definitions
Methotrexate Clearance GWAS	phv00195887	Race genetcially determined using STRUCTURE with genome-wide mapping array
Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)	phv00071469	Race/Ethnicity
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00082641	RACE
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00084444	RACE / ETHNICITY
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00085775	RACE / ETHNICITY
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086261	RACE / ETHNICITY
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086729	RACE / ETHNICITY
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087074	RACE AND ETHNICITY
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174585	RACE / ETHNICITY
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175855	RACE
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175876	RACE
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175967	RACE GROUP
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176008	RACE / ETHNICITY
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00219021	RACE
Multiethnic Cohort (MEC) Breast Cancer Genetics	phv00173160	Self reported race/ethnicity
National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): Medulloblastoma	phv00173797	Race/Ethnicity
National Children's Study Vanguard Study Formative Research Study (NCS)	phv00196031	Self-reported subject race
NEI Age-Related Eye Disease Study (AREDS)	phv00053858	RACE OR ETHNIC BACKGROUND (ALL PARTICIPANTS)
NEI Age-Related Eye Disease Study (AREDS) - Genetic Variation in Refractive Error Substudy	phv00164695	Race of participant
NEI Ocular Hypertension Treatment Study (OHTS)	phv00160402	Race of participant
Neurodevelopmental Genomics: Trajectories of Complex Phenotypes	phv00194910	Race and ethnicity
Next Generation Mendelian Genetics: Atypical Werner Syndrome	phv00167489	Race of the participant.
Next Generation Mendelian Genetics: Auriculocondylar Syndrome (ACS)	phv00197295	Race of participant
Next Generation Mendelian Genetics: Congenital Hyperinsulinism	phv00174174	Race of participant
Next Generation Mendelian Genetics: Ehlers-Danlos Syndrome Type VIII	phv00174277	Race of participant
Next Generation Mendelian Genetics: Familial Combined Hyperlipidemia	phv00174256	Race of participant
Next Generation Mendelian Genetics: Hereditary Neurological Disorders	phv00200321	Race of participant
Next Generation Mendelian Genetics: Malignant Hyperthermia	phv00167503	Race of participant
Next Generation Mendelian Genetics: Muscle Hypertrophy	phv00174293	Race of participant
Next Generation Mendelian Genetics: Neonatal Diabetes	phv00174159	Race of participant
NHGRI Tumor Sequencing Project (Lung Adenocarcinoma)	phv00071770	Race of participant
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190301	Self report race [European American, African American]
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122991	Subject's Race
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122993	Subject's Race description
NHLBI GO-ESP Family Studies: Idiopathic Bronchiectasis	phv00171842	Subject race
NHLBI GO-ESP Family Studies: Pulmonary Arterial Hypertension	phv00191052	Race of participant
NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI)	phv00160312	European American; African American
NHLBI GO-ESP: Family Studies (Aortic Disease)	phv00179492	Race of participant
NHLBI GO-ESP: Family Studies (Dilated Cardiomyopathy)	phv00181168	Race of participant [White, Black or African American, American Indian/Alaska Native, More than one race, Unknown or not reported, Native Hawaiian or Other Pacific Islander]
NHLBI GO-ESP: Family Studies (Mendelian Lipid Disorders)	phv00195791	Race of participant [African American, Asian, Caucasian, Hispanic, Non-Hispanic]
NHLBI GO-ESP: Family Studies: (Familial Atrial Fibrillation)	phv00181915	Race of participant [African American, Asian, Caucasian, Hispanic, Non-Hispanic]
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00190417	Self report race [European American, African American]
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190557	Self report race [European American, African American]
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00181176	Self report race
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS)	phv00179586	Self reported Race
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178025	Self report race
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (SWISS)	phv00174110	SELF REPORTED RACE OF PARTICIPANT
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)	phv00181855	Race of participant
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (COPDGene)	phv00170989	ESP_RACE
NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP	phv00161366	SELF REPORTED RACE OF PARTICIPANT
NIA - Late Onset Alzheimer's Disease and National Cell Repository for Alzheimer's Disease Family Study: Genome-Wide Association Study for Susceptibility Loci	phv00071273	Subject's race
NIDDK Gene discovery in FSGS	phv00202569	Race of participant
NIDDK Gene discovery in VUR	phv00202546	Race of participant
NIDDK IBD Genetics Consortium Ulcerative Colitis Genome-Wide Association Study	phv00162978	Race (self-report)
NIDDK IBDGC Crohn's Disease Genome-Wide Association Study	phv00057993	Race (self-report)
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00024104	Subject's race
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00024163	Subject's race
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00088179	Race of participant
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00158870	Race of participant
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00200478	Race of participant
NINDS Parkinsonism Study	phv00000182	Race of the subject
NINDS Repository Cerebrovascular Disease/Stroke Study	phv00000279	Race of the subject
NINDS Repository Motor Neuron Disease/ALS Study	phv00000371	Race of the subject
NINDS Repository Neurologically Normal Control Collection	phv00000222	Race of the subject
NINDS Stroke Genetics Network (SiGN)	phv00190674	Self reported race
Northwestern NUgene Project: Type 2 Diabetes	phv00158821	Subject's race
OMRF SLEGEN GWAS Data from European-American Women with Lupus	phv00076098	Race of subject
PAGE: Epidemiologic Architecture for Genes Linked to Environment (EAGLE) - BioVU Cancer Project	phv00196395	Race of Participant
Pediatric Cardiac Genetics Consortium (PCGC)	phv00180740	Race
Pediatric Cardiac Genetics Consortium (PCGC)	phv00181009	Race
Pediatric Cardiac Genetics Consortium (PCGC)	phv00181064	Race
PGC: the PUWMa GWAS of ADHD	phv00159879	Race of participant
PGRN Antidepressant Medication Pharmacogenomic Study (AMPS)	phv00195980	Race description
PGRN Antidepressant Medication Pharmacogenomic Study (AMPS)	phv00195981	Race code
PGRN-RIKEN: Identification of Genetic Predictors of ACE Inhibitor-Associated Angioedema	phv00190845	Race of participant
PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation	phv00173382	Race of participant
POLYGEN	phv00163176	Subject's race
PREDICT-HD Huntington Disease Study	phv00172058	Racial Category
Resource for Genetic Epidemiology Research on Aging (GERA)	phv00196837	Self-reported race.
Risk Assessment of Cerebrovascular Events (RACE) Study	phv00167694	Subject's ethnicity
Risk Assessment of Cerebrovascular Events (RACE) Study	phv00167706	Subject's ethnicity
Risk Assessment of Cerebrovascular Events (RACE) Study	phv00167713	Subject's ethnicity
RNA-Seq studies of Gene Expression in Cells and Networks in FI and ACC in Autism	phv00190496	Subject's race
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants), GAIN	phv00019967	Predominant race/ethnicity - See also NIDDK - GoKinD phs000088: RACE
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070937	Race of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070998	Race of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071048	Race of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071106	Race of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071156	Race of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071214	Race of participant
SNPs and Extent of Atherosclerosis (SEA) Study	phv00159043	RACE
STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)	phv00129626	Race of participant
Study of Addiction: Genetics and Environment (SAGE)	phv00022893	Participant's self-identified race
TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2	phv00167583	NAACCR Race
TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1	phv00167560	NAACCR Race
TARGET: Neuroblastoma (NBL)	phv00167622	NAACCR Race
Targeted Sequencing of GWAS Loci in Cleft Lip and Palate	phv00201754	Race of participant
The CARDIA-GENEVA Study	phv00129486	Race [verified at Exam 2]
The Collaborative Study on the Genetics of Alcoholism (COGA)	phv00217638	Race (WHITE/BLACK/ASIAN/OTHER/UNK.)
The Detroit Neighborhood Health Study (DNHS)	phv00174398	Race of participant. Multiple answers allowed. (SELECTION
The Detroit Neighborhood Health Study (DNHS)	phv00174399	Race of participant. Multiple answers allowed. (SELECTION
The Detroit Neighborhood Health Study (DNHS)	phv00174400	Race of participant. Multiple answers allowed. (SELECTION
The Effect of the Menstrual Cycle on the Normal Human Breast	phv00193893	Race
The Familial Intracranial Aneurysm Linkage Study (FIA)	phv00191124	Race of participant
The Gene Partnership (TGP) - eMERGE Data	phv00171964	Race of participant - as reported by participant
The Genetic Architecture of Smoking and Smoking Cessation	phv00162807	Participant's self-identified race
The Genetic Architecture of Smoking and Smoking Cessation	phv00162953	Participant's self-identified race
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00159328	Race - Black/Other/White
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00159329	Patient's self-reported race category
The Human Virome and Febrile Illness in Children	phv00098406	Race of participant
The Neonatal Microbiome and NEC	phv00091260	Race of subject
The Sea Islands Genetic Network (SIGNET)	phv00163536	Self-reported race
Towards a Genomic Understanding of Myeloma	phv00159452	Participant's race using US census definitions
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing	phv00066338	Race, ethnicity of participant
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing	phv00066352	Race, ethnicity of participant
University of Miami Study on Genetics of Autism and Related Disorders (AutismDisorders)	phv00171541	Race of participant
University of Michigan Clinical Sequencing Exploratory Research (CSER)	phv00197134	Race of participant [African American, Asian, Caucasian, Hispanic, Non-Hispanic]
Vanderbilt Genome-Electronic Records (VGER) Project: QRS Duration	phv00077278	Race of participant
Whole Exome Sequencing for Colorectal Cancer	phv00163737	Race of participant [white]
Whole Exome Sequencing for Familial Intracranial Aneurysm (FIA I-II) Study	phv00193933	Race of participant
Whole Exome Sequencing in Familial Parkinson Disease	phv00161351	Race of subject
Whole Genome Association Study of Bipolar Disorder	phv00013850	Subject's self-reported race. DIGS2
Whole Genome Association Study of Bipolar Disorder	phv00016943	Cover race. Self-reported race. DIGS4
Whole Genome Association Study of Visceral Adiposity in the HABC Study	phv00071827	Race
Whole Genome Comparisons of Breast Cancers and their Xenotransplants	phv00195711	Subject's race
Whole Genome Sequencing of Triple Negative Breast Cancer	phv00124474	Race of participant
Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma	phv00168014	Race of participant
Whole-Genome Sequencing of Acute Myeloid Leukemia	phv00073675	Subject's Race
Women's Health Initiative	phv00078450	Racial or ethnic group

Mapping for PX091601_Technician_ID

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Jackson Heart Study (JHS) Cohort	phv00128199	Spirometry technician identifier (3 Digit ID unique to each technician)

Mapping for PX091601_Testing_Position

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083453	TEST POSITION
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083688	TEST POSITION
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087679	TEST POSITION

Mapping for PX091601_Time_To_PEF

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083480	TIME TO PEAK EXPIRATORY FLOW (sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083715	TIME TO PEAK EXPIRATORY FLOW (sec)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087706	TIME TO PEAK EXPIRATORY FLOW (sec)

Mapping for PX091601_VC

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Framingham Cohort	phv00000753	LUNG FUNCTION: VITAL CAPACITY, ACTUAL, EXAM 5
Framingham Cohort	phv00000832	LUNG FUNCTION: VITAL CAPACITY, EXAM 6

Mapping for PX091601_Weight

dbGAP Study	dbGAP Variable	dbGAP Variable Description
A Genome-Wide Association Study in Breast Cancer Patients from the SUCCESS Trial	phv00174067	Weight (to calculate BMI)
A Genome-Wide Association Study of Peripheral Arterial Disease	phv00076115	Subject's weight at enrollment
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091446	WEIGHT TO THE NEAREST LB Q4
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091466	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091479	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092562	WEIGHT TO NEAREST LB Q1
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092574	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092584	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00093440	WEIGHT 4
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00097917	WEIGHT TO THE NEAREST LB Q4
CARDIA Cohort	phv00114073	WEIGHT - MON 12
CARDIA Cohort	phv00114831	SUBJECT'S WEIGHT IN POUNDS. Q 3
CARDIA Cohort	phv00115857	SUBJECT'S WEIGHT (LBS). Q 2
CARDIA Cohort	phv00117231	SUBJECT'S WEIGHT (LBS). Q 2a
CARDIA Cohort	phv00117926	WEIGHT - MON 96
CARDIA Cohort	phv00118137	WEIGHT
CARDIA Cohort	phv00118251	WEIGHT
CARDIA Cohort	phv00119094	SUBJECT'S WEIGHT (LBS). Q 2a
CARDIA Cohort	phv00119573	WEIGHT (LBS) - FORM 53
CARDIA Cohort	phv00120996	SUBJECT'S WEIGHT (LBS). Q 2a
Cardiovascular Health Study (CHS) Cohort	phv00098848	WEIGHT (lb)
Cardiovascular Health Study (CHS) Cohort	phv00099349	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00100383	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00101789	WEIGHT IN POUNDS
Cardiovascular Health Study (CHS) Cohort	phv00102454	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00104028	WEIGHT IN POUNDS AT YEAR 3 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00104759	WEIGHT IN POUNDS
Cardiovascular Health Study (CHS) Cohort	phv00105147	WEIGHT
Cardiovascular Health Study (CHS) Cohort	phv00105414	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00106776	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00107778	WEIGHT IN POUNDS AT YEAR 6 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00108569	WEIGHT IN POUNDS AT YEAR 7 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00109512	WEIGHT IN POUNDS AT YEAR 8 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00110376	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00198931	2 weight in kg (multiply by 10)
Cardiovascular Health Study (CHS) Cohort	phv00197432	Weight in kilograms
CCDG: Dental Caries and CL/P in Guatemala	phv00164777	Weight in kilograms.
Cebu Longitudinal Health and Nutrition Survey (CLHNS)	phv00173310	Weight
Chronic Renal Insufficiency Cohort Study (CRIC)	phv00173256	Weight (kg)
CIP: Obesity-Diabetes Familial Risk	phv00191157	Subject's weight
Columbia University Study of Caribbean Hispanics and Late Onset Alzheimer's disease	phv00180594	Weight of subject
CPMCRI Breast Health Cohort	phv00162745	Participant's weight
CPTAC Proteogenomic Confirmatory Study	phv00225399	Provide the weight of the participant measured in kilograms.
Cutaneous Microbiome in Psoriasis (HMP Demonstration Study)	phv00196073	Subject's weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00025689	Current weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026032	Current weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026033	Current height
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026469	CBL00: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026683	CBL6: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027263	Patient's weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027317	CBL1: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027384	CBL2: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027428	Body weight (kg): baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027431	Body weight (kg): quarterly visit 01
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027434	Body weight (kg): quarterly visit 02
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027437	Body weight (kg): quarterly visit 03
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027444	Body weight (kg): quarterly visit 04
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027447	Body weight (kg): quarterly visit 05
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027450	Body weight (kg): quarterly visit 06
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027453	Body weight (kg): quarterly visit 07
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027460	Body weight (kg): quarterly visit 08
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027463	Body weight (kg): quarterly visit 09
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027466	Body weight (kg): quarterly visit 10
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027469	Body weight (kg): quarterly visit 11
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027476	Body weight (kg): quarterly visit 12
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027479	Body weight (kg): quarterly visit 13
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027482	Body weight (kg): quarterly visit 14
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027485	Body weight (kg): quarterly visit 15
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027492	Body weight (kg): quarterly visit 16
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027495	Body weight (kg): quarterly visit 17
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027498	Body weight (kg): quarterly visit 18
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027501	Body weight (kg): quarterly visit 19
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027508	Body weight (kg): quarterly visit 20
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027511	Body weight (kg): quarterly visit 21
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027514	Body weight (kg): quarterly visit 22
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027517	Body weight (kg): quarterly visit 23
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027524	Body weight (kg): quarterly visit 24
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027527	Body weight (kg): quarterly visit 25
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027530	Body weight (kg): quarterly visit 26
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027533	Body weight (kg): quarterly visit 27
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027540	Body weight (kg): quarterly visit 28
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027543	Body weight (kg): quarterly visit 29
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027546	Body weight (kg): quarterly visit 30
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027549	Body weight (kg): quarterly visit 31
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027556	Body weight (kg): quarterly visit 32
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027559	Body weight (kg): quarterly visit 33
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027562	Body weight (kg): quarterly visit 34
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027565	Body weight (kg): quarterly visit 35
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027572	Body weight (kg): quarterly visit 36
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027575	Body weight (kg): close-out
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028551	CBL7: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028927	Current weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028929	Patient's desired weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00029760	Patient's current weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030104	Patient's weight (kg) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030409	CBL3: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030611	Weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030612	Weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030613	Weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030614	Weight: 4th measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030688	Patient's weight (kg) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031025	CBL9: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031092	CBL8: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031247	Current weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031598	CBL4: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031756	CBL5: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00032580	CBL10: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034114	Patient's weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034523	Weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048913	Q1a. Physical examination, weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048914	Q1b. Physical examination, weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048915	Q1c. Physical examination, weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048916	Q1d. Physical examination, weight: 4th measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049331	Q1a. Physical examination, weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049332	Q1b. Physical examination, weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049333	Q1c. Physical examination, weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049334	Q1d. Physical examination, weight: 4th measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065872	Q1a. Physical examination, weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065873	Q1b. Physical examination, weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065874	Q1c. Physical examination, weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065875	Q1d. Physical examination, weight: 4th measurement
Dental Caries GWAS	phv00090202	Weight in kilograms (kg)
Dental Caries GWAS	phv00165475	Weight in kilograms
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090694	Average weight, in kilograms
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090712	Weight - a
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090713	Weight - b
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090714	Weight - c
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090715	Weight - avg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090806	Weight a - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090807	Weight a - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090808	Weight a - kg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090809	Weight b - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090810	Weight b - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090811	Weight b - kg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090812	Weight c - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090813	Weight c - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090814	Weight c - kg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090815	Weight d (Average) - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090816	Weight d (Average) - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090817	Weight d (Average) - kg
eMERGE Genome-Wide Association Studies of Obesity (Metabochip)	phv00163771	Weight prior to bariatric surgery.
eMERGE Network Combined Dataset	phv00182436	Subject's weight at enrollment
FaceBase Study of Facial Shape in Tanzania: CIDR	phv00202482	Weight in kg
Familial Exome Sequencing in Rare Pediatric Phenotypes	phv00179542	Subject's weight
Family Investigation of Nephropathy and Diabetes (FIND) Study	phv00161442	Weight at enrollment
Framingham Cohort	phv00177537	Anthropometry: Weight
Framingham Cohort	phv00164574	Weight in kg. at baseline
Framingham Cohort	phv00000541	WEIGHT, EXAM 1
Framingham Cohort	phv00000552	MEDIAN WEIGHT
Framingham Cohort	phv00000632	WEIGHT, EXAM 2
Framingham Cohort	phv00000646	WEIGHT, EXAM 3
Framingham Cohort	phv00000679	WEIGHT, EXAM 4
Framingham Cohort	phv00000746	WEIGHT, EXAM 5
Framingham Cohort	phv00000829	WEIGHT, EXAM 6
Framingham Cohort	phv00000915	WEIGHT, EXAM 7
Framingham Cohort	phv00001037	WEIGHT (WHOLE POUNDS)
Framingham Cohort	phv00001189	BODY WEIGHT
Framingham Cohort	phv00001366	BODY WEIGHT
Framingham Cohort	phv00001563	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00001807	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002022	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002206	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002427	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002670	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00003244	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00003302	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00003668	WEIGHT
Framingham Cohort	phv00004084	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00004526	WEIGHT (POUNDS, TO NEAREST POUND)
Framingham Cohort	phv00005541	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00005921	WEIGHT (TO NEAREST POUND, WITHOUT SHOES AND IN LIGHT CLOTHES)
Framingham Cohort	phv00006033	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00006328	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00006671	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00007098	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00007569	BODY WEIGHT
Framingham Cohort	phv00007676	BODY WEIGHT (KG)
Framingham Cohort	phv00007678	BODY WEIGHT (LB)
Framingham Cohort	phv00008713	WEIGHT IN POUNDS
Framingham Cohort	phv00009100	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00009552	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00010108	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00010498	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00021229	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00055259	Weight in kilograms
Framingham Cohort	phv00055291	Weight in kilograms
Framingham Cohort	phv00056838	Weight in kilograms
Framingham Cohort	phv00070552	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00072335	WEIGHT (TO NEAREST POUND)
GAW16 Framingham and Simulated Data	phv00051739	WEIGHT IN POUNDS EXAM 1
GAW16 Framingham and Simulated Data	phv00051740	WEIGHT IN POUNDS EXAM 4
GAW16 Framingham and Simulated Data	phv00051741	WEIGHT IN POUNDS EXAM 7
GAW16 Framingham and Simulated Data	phv00051742	WEIGHT IN POUNDS EXAM 11
GAW16 Framingham and Simulated Data	phv00051807	WEIGHT IN POUNDS EXAM 1
GAW16 Framingham and Simulated Data	phv00051808	WEIGHT IN POUNDS EXAM 3
GAW16 Framingham and Simulated Data	phv00051809	WEIGHT IN POUNDS EXAM 5
GAW16 Framingham and Simulated Data	phv00051810	WEIGHT IN POUNDS EXAM 7
GAW16 Framingham and Simulated Data	phv00051848	WEIGHT IN POUNDS EXAM 1
Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP)	phv00163636	Current weight of subject.
Geisinger eMERGE - MyCode Project	phv00163394	Current weight of subject.
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00082611	Weight
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00082613	Weight Units
Genes and Blood Clotting Study (GABC)	phv00124353	Participant weight at time of registration
Genetic Epidemiology of COPD (COPDGene)	phv00159591	Weight [kg]
Genetic Factors Linked with Renal Disease Progression (PediGFR) - CKiD	phv00195603	Average Weight
Genetic Multiple Sclerosis Associations - GeneMSA	phv00073450	Weight
Genetic Multiple Sclerosis Associations - GeneMSA	phv00073451	Weight - units
GENEVA Diabetes Study (NHS/HPFS)	phv00076250	Weight in kg at time of blood draw
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00022827	Weight to the nearest lb at visit 1
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00080697	Weight to the nearest lb at visit 2
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00080709	Weight to the nearest lb at visit 3
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00080719	Weight to nearest lb at visit 4
Genome-Wide Association Study of Schizophrenia	phv00020423	Please enter below your current weight in pounds:
Genome-Wide Association Study of Schizophrenia	phv00034789	Please enter below your current weight in pounds:
Genomic Wide Scans for Female Osteoporosis Genes	phv00161537	Weight of study subject.
Genotype-Tissue Expression (GTEx)	phv00169069	Weight Units (Demography)
Genotype-Tissue Expression (GTEx)	phv00169068	Weight
Group Health/UW Aging and Dementia eMERGE Study	phv00088221	Weight
GWAS for Genetic Determinants of Bone Fragility	phv00065520	Weight at primary study visit
GWAS of Breast Cancer in the African Diaspora	phv00172018	Body weight
GWAS on Cataract and HDL in the PMRP	phv00181815	How much {do you/does the participant} weigh without clothes or shoes? [If {you are/she is} currently pregnant, how much did {you/she} weigh before your pregnancy?]
GWAS on Cataract and HDL in the PMRP	phv00073576	Subject's weight at enrollment
HAPO Maternal Glycemia and Birthweight GEI Study	phv00098541	Mother's pre-pregnancy weight
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158675	Weight in pounds
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158676	Weight in kilograms
Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia	phv00161489	Subject weight
Jackson Heart Study (JHS) Cohort	phv00125861	2: Weight to nearest kilogram
Jackson Heart Study (JHS) Cohort	phv00181211	Weight in kilograms at first participant visit
Jackson Heart Study (JHS) Cohort	phv00165337	Weight in kilograms at baseline
Location and Function of Cytosine-5 Methylation in RNA	phv00226199	Subject's weight
Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)	phv00071649	Please enter below your current weight in pounds:
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00082685	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083472	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083707	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00084484	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00085800	WEIGHT (lbs.)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086299	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086752	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087079	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087698	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176168	WEIGHT AT CT
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176060	BODY COMPOSITION SCALE: CURRENT BODY WEIGHT (kg)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176055	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175859	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174745	WEIGHT AT CT
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174637	BODY COMPOSITION SCALE: CURRENT BODY WEIGHT (kg)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174632	WEIGHT (lbs)
NEIGHBOR Consortium Glaucoma GWAS	phv00129668	Weight at enrollment (lbs) 999: Missing
Neurodevelopmental Genomics: Trajectories of Complex Phenotypes	phv00194236	Medical: Weight: lb
NHGRI Genome-Wide Association Study of Venous Thromboembolism (GWAS of VTE)	phv00121873	Weight at current appt date
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190307	Weight in kg. at first participant visit
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00123776	Weight (kg)
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122639	Weight in kilograms
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163953	Weight in kg. at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190565	Weight in kg. at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165170	Weight in kg. at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS)	phv00179602	Weight in kg
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178036	Weight in kg at baseline
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)	phv00181865	Weight of participant at baseline
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of Chronic Obstructive Pulmonary Disease)	phv00160352	ESP, weight in lbs. at baseline
NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP	phv00165268	BASELINE WEIGHT IN KG
NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)	phv00200563	Prepregnancy weight (lbs)
NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)	phv00200564	Weight (in lbs)
PAGE: Multiethnic Cohort (MEC)	phv00163105	Weight (kg) reported at baseline
Pediatric Cardiac Genetics Consortium (PCGC)	phv00180764	Weight in kilograms
PediGFR - 4C Study Cohort	phv00221103	Weight
PediGFR - ESCAPE Trial Cohort	phv00221126	Weight
PGRN Antidepressant Medication Pharmacogenomic Study (AMPS)	phv00195999	Baseline Weight
PGRN-RIKEN MA.27 Mayo Aromatase Inhibitor Musculoskeletal Adverse Events Study	phv00076277	Weight
PGRN-RIKEN NSABP Prevention Study	phv00124506	Weight
POLYGEN	phv00160482	Weight of participant
Sensitivity to the subjective effects of amphetamine	phv00221232	Weight of participant
Sequencing of Targeted Genomic Regions Associated with Smoking	phv00217971	Participant weight in pounds
Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency	phv00090683	Subject's weight
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070941	Baseline weight
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071001	Weight at follow-up visit
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071052	Baseline Weight
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071109	Weight at Follow-up
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071160	Baseline Weight (kg)
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071217	Weight at Follow-up (kg)
STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)	phv00129622	Weight
Study of Addiction: Genetics and Environment (SAGE)	phv00022913	Participant's weight in pounds
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171725	Weight at the fifth study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171722	Weight at the second study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171724	Weight at the fourth study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171723	Weight at the third study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171720	Weight at the most recent study visit for which we have data for this participant
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171721	Weight at the first study visit
The CARDIA-GENEVA Study	phv00129531	Subject's weight [in LBS] at Exam 5
The CARDIA-GENEVA Study	phv00129533	Subject's weight [in LBS] at Exam 6
The CARDIA-GENEVA Study	phv00129535	Subject's weight [in LBS] at Exam 7
The CARDIA-GENEVA Study	phv00129529	Subject's weight [in LBS] at Exam 4
The CARDIA-GENEVA Study	phv00129527	Subjects weight [in LBS] at Exam 3
The CARDIA-GENEVA Study	phv00129525	Subjects weight in pounds at Exam 2
The CARDIA-GENEVA Study	phv00129522	Participant's weight [in LBS] at Exam 1
The Cardiopulmonary Effects of Particulate Exposure	phv00252413	Subject's weight
The Effect of the Menstrual Cycle on the Normal Human Breast	phv00193892	Weight in pounds
The Genetic Architecture of Smoking and Smoking Cessation	phv00162809	Participant's weight in pounds
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00180536	Weight (pounds)
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00180469	Weight of participant (lbs)
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00179643	Weight (pounds)
The Human Virome and Febrile Illness in Children	phv00098426	Weight of the participant during collection of sample
The Sea Islands Genetic Network (SIGNET)	phv00163537	Weight at enrollment
University of Miami Study on Genetics of Autism and Related Disorders (AutismDisorders)	phv00171542	Subject's weight
Whole Genome Association Study of Bipolar Disorder	phv00035240	Please enter below your current weight in pounds. (Participants with European ancestry)
Whole Genome Association Study of Bipolar Disorder	phv00054548	Please enter below your current weight in pounds. (African American participants)
Whole-Genome Sequencing of Acute Myeloid Leukemia	phv00073673	Subject's weight in kilograms
Women's Health Initiative	phv00077673	Current weight lbs
Women's Health Initiative	phv00077799	Current weight lbs
Women's Health Initiative	phv00077909	Current weight lbs
Women's Health Initiative	phv00078111	Current weight lbs
Women's Health Initiative	phv00078235	Current weight lbs
Women's Health Initiative	phv00079558	Weight, lbs
Women's Health Initiative	phv00079859	F80 Weight kg